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Abstract
DNA sequence copy number has been shown to be associated with cancer de-
velopment and progression. Array-based Comparative Genomic Hybridization
(aCGH) is a recent development that seeks to identify the copy number ratio at
large numbers of markers across the genome. Due to experimental and biolog-
ical variations across chromosomes and across hybridizations, current methods
are limited to analyses of single chromosomes. We propose a more powerful ap-
proach that borrows strength across chromosomes and across hybridizations. We
assume a Gaussian mixture model, with a hidden Markov dependence structure,
and with random effects to allow for intertumoral variation, as well as intratumoral
clonal variation. For ease of computation, we base estimation on a pseudolikeli-
hood function. The method produces quantitative assessments of the likelihood
of genetic alterations at each clone, along with a graphical display for simple vi-
sual interpretation. We assess the characteristics of the method through simulation
studies and through analysis of a brain tumor aCGH data set. We show that the
pseudolikelihood approach is superior to existing methods both in detecting small
regions of copy number alteration and in accurately classifying regions of change
when intratumoral clonal variation is present.
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ABSTRACT
DNA sequence copy number has been shown to be associated with cancer de-
velopment and progression. Array-based Comparative Genomic Hybridiza-
tion (aCGH) is a recent development that seeks to identify the copy number
ratio at large numbers of markers across the genome. Due to experimen-
tal and biological variations across chromosomes and across hybridizations,
current methods are limited to analyses of single chromosomes. We propose
a more powerful approach that borrows strength across chromosomes and
across hybridizations. We assume a Gaussian mixture model, with a hidden
Markov dependence structure, and with random effects to allow for intertu-
moral variation, as well as intratumoral clonal variation. For ease of com-
putation, we base estimation on a pseudolikelihood function. The method
produces quantitative assessments of the likelihood of genetic alterations at
each clone, along with a graphical display for simple visual interpretation.
We assess the characteristics of the method through simulation studies and
through analysis of a brain tumor aCGH data set. We show that the pseudo-
likelihood approach is superior to existing methods both in detecting small
regions of copy number alteration and in accurately classifying regions of
change when intratumoral clonal variation is present.
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1 Introduction
DNA sequence copy number changes in tumor cells are associated with can-
cer development and progression (Forozan et al., 2000; Kallioniemi et al.,1994;
Tirkkonen et al., 1998). Copy number changes are typically manifest as losses
or gains of chromosomes or chromosomal regions. A chromosomal loss in a
tumor is classically associated with under-expression of genes whose activity
prevents tumor development, so-called tumor suppressor genes. Copy num-
ber gains, on the other hand, are often associated with over-expression of genes
that promote cell growth, so-called oncogenes. Detection and mapping of such
gains and losses in tumor genomes will ultimately lead to identification of criti-
cal genes associated with these diseases, and eventually to improved therapeu-
tic approaches.
Initial attempts to identify regions of copy number variation included kary-
otyping and directed molecular genetic studies. The inability of these meth-
ods to characterize chromosomal changes in detail (karyotyping) or to exam-
ine large regions of the genome (directed molecular methods) led to the de-
velopment of more global screening approaches, such as comparative genomic
hybridization (CGH) (Kallioniemi et al., 1992). CGH entails the simultaneous
hybridization of differentially labeled test DNA and reference DNA to nor-
mal chromosomal spreads. Test DNAs are obtained from tumors and reference
DNA is typically obtained from lymphocytes of a healthy individual. Two sep-
arate fluorescent dyes (usually red-fluorescent dye Cy5 for the reference sample
and green-fluorescent dye Cy3 for the tumor sample) are used to label probes
1
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for hybridization to metaphase chromosomes, thus allowing a fluorescence in-
tensity ratio to be calculated for each approximate location on a particular chro-
mosome.
Array-based comparative genomic hybridization (aCGH) is a recent modifi-
cation of CGH that provides greater resolution by using microarrays of DNA
fragments rather than metaphase chromosomes (Pinkel et al., 1998; Snijders et
al., 2001). These arrays can be generated with different types of DNA prepa-
rations. One methods uses bacterial artificial chromosomes (BACs), each of
which consists of a 100 - 200 kilobase DNA segment. Other arrays are based
on cDNAs (Pollack et al., 1999; Pollack et al., 2002) or oligonucleotide frag-
ments (Lucito et al., 2000). As in CGH analysis, the resultant map of gains and
losses is a result of calculating fluorescence ratios. By arraying large numbers
of DNA sequences, however, one can potentially use aCGH to determine gains
and losses with high resolution (e.g., at an individual gene level) across the
entire genome (e.g., with arrays that “tile” the whole genome).
The determination of patterns of genomic gains and losses translates into a
number of possible uses in cancer diagnosis and management. For instance,
in a group of patients diagnosed with the same pathological type of cancer,
genetic subtyping can predict markedly different responses to chemotherapies
and can offer powerful prognostic information. aCGH could therefore prove
a powerful tool for investigating associations between genetic alterations and
pathological diagnosis, response to individual therapies and clinical outcome.
For example, a recent study has as its focus the evaluation of copy number
gains and losses in tissue taken from malignant gliomas, a common type of
2
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human brain tumor (Mohapatra et al., 2006). Figure 1 displays the aCGH data
for four tumors from this study.
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Figure 1: The log2 fluorescence ratios from four oligodendroglioma samples.
A number of statistical methods have been proposed for the analysis of aCGH
data. Such methods have taken one of two approaches. One approach prespec-
ifies the types of underlying, but unobserved, copy number alteration events
(e.g., gain, loss, no-change). A second approach makes no such assumptions,
but instead attempts to identify locations of log2 ratio mean change (i.e., break-
points) and to estimate the value of those means. A major limitation of all
currently proposed methods is their analysis of each chromosome, of each hy-
bridization, separately. That is, current methods do not utilize the entire avail-
able dataset to estimate the features that are shared in common among chro-
3
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mosomes and hybridizations. Additionally, some methods fail to account for
dependence between clones. Finally, the interpretation of results obtained from
many existing methods does not emerge naturally from the original analysis,
but requires a second-stage of analysis and additional assumptions.
In this paper, we propose a joint analysis of aCGH data, via a Gaussian mixture
model with a local Hidden Markov dependence structure, that fully exploits
the entire dataset to efficiently estimate the common features of the genetic al-
terations. At the same time, our approach accommodates the variability within
chromosomes, between chromosomes, and between hybridizations. For com-
putational feasibility, we use a pseudolikelihood function as the basis for esti-
mation. As it is based on a probability model, our approach produces quanti-
tative assessments of the likelihood of the various genetic events at each clone,
via posterior probabilities, which aid in interpretation of results. In addition,
the method produces a graphical display of this information. In both real and
simulated data sets, the proposed pseudolikelihood approach appears to be
more sensitive than existing methods to small segments of true copy number
change. Additionally, simulation studies show that when variation in gain and
loss levels exists within hybridizations, the proposed method more effectively
classifies regions of change.
In Section 2 we provide a brief outline of aCGH data characteristics. Section 3
reviews and assesses existing methods of aCGH data analysis. In Section 4 we
present the theoretical framework for our method along with proposed meth-
ods for identification of gains and losses and for identification of copy number
breakpoint locations. We apply our proposed to the glioma study and present
4
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the results in Section 5. Section 6 presents of the results of several simulation
studies. We conclude with a discussion in Section 7.
2 aCGH Data Characteristics and Assumptions
It is of interest to estimate the true sequence of underlying copy number ratios
that generated the observed sequence of fluorescence ratios. In the idealized
setting in which the reference DNA does not contain any copy number alter-
ations, the genomic regions of copy number gains will have ratios greater than
or equal to 3/2 (i.e., log2(3/2) ≥ 1.58) and regions of copy number loss should
have ratios equal to 1/2 (i.e., log2(1/2) = −1). Logarithms of the ratios are com-
monly used because the ratios are dependent on absolute magnitude and are
often highly skewed; logged intensities often provide a better sense of the true
variation (Amaratunga et al., 2004). Allowing for random error, often assumed
to be normal with mean zero, the underlying ratio of the true copy number of
each test (tumor) clone to the reference clone can then be estimated given the
observed data.
A variety of biological and experimental factors cause the observed log2 ratios
to deviate from their theoretical values. For one, the copy number of the refer-
ence sample might not be two (Iafrate et al., 2004). Also, the test sample is not
pure; the tumor sample is typically contaminated with some normal cells. In
the event of true copy number alteration, the presence of normal cells (exhibit-
ing no copy number change) lowers the absolute magnitude of the log2 ratios.
Deviation from the expected ratios might also be due to intratumoral clonal
5
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variation (Okada et al., 2003); variation. That is, the mean log2 ratio magni-
tudes corresponding to a particular copy number alteration event (e.g., single
copy number gain) may vary both within and between chromosomes in a given
tumor.
Normalization of the log2 ratios is typically conducted in an attempt to adjust
for sources of systematic variation. Since these effects are often not known or
measured, most aCGH methodologies incorporate global normalization tech-
niques, centering the data about the sample mean or median for a given hy-
bridization (Fridlyand et al., 2004). An alternative approach is available when
a tumor type has not been shown to have copy number gain or loss in a given
chromosome by other laboratory methods. In this case, that chromosome can
be used for normalization by using its median log2 ratio to center all log2 ra-
tios on that hybridization. More refined approaches have been suggested as
well; for example, Dudoit et al. (2002) and Yang et al. (2002) proposed meth-
ods of normalization that adjust for spatial effects on the array. Such methods,
however, may or may not be appropriate for aCGH data. In summary, nor-
malization remains imperfect and accurate estimation of the copy number is
unlikely. It is assumed, however, that changes in the observed, normalized log2
ratios correspond directly to changes in the true copy numbers.
3 Current Methods of Single-Chromsome Analysis
All current aCGH analysis methods treat each chromosome of each hybridiza-
tion separately. This is motivated by the presumed independence of chromo-
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somes and hybridizations. Also, this acknowledges that the magnitudes of the
log2 ratios for loss or gain may vary across chromosomes and across hybridiza-
tions (e.g., Fridlyand et al., 2004). Current methods can be classified as those
that prespecify the number and type of gain and loss events on a chromosome
or as those that identify regions of common log2 ratio magnitude. In this section
we review these methods and summarize their limitations.
3.1 Current Methods: Prior Specification of Underlying Events
One class of analytic approaches is predicated on a priori specification of the un-
derlying, but unobserved, copy number event types. To date, all such methods
have specified three possible events: gain, loss, and no-change. One example of
this is a threshold approach (e.g., Pollack et al., 1999; Weiss et al., 2003; Aguirre
et al., 2004). This involves estimation of the variability of the log2 ratios that cor-
respond to no genetic alteration using normal-normal hybridizations. Assum-
ing, then, that log2 ratios corresponding to no genetic alteration in the tumor are
normally distributed with mean zero, regions of gain and loss are identified as
those clones with log2 ratios in the upper and lower tails of the distribution.
A second example is a full mixture model approach in which all parameters
governing the distributions of the log2 ratios associated with each of the dif-
ferent copy number events are estimated. For example, Hodgson et al. (2001)
assumed that the data from a given chromosome for a given hybridization are
distributed as a three-component (loss, no-change, gain) Gaussian mixture. As
in the simpler threshold approach based on the normal-normal hybridizations,
the variability of the no-change event is the parameter of interest. The mixture
7
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model approach differs from the threshold approach in that normal-normal hy-
bridizations are not required. Both approaches assume independence between
clones.
3.2 Current Methods: Segmentation
The second class of analytic approaches does not prespecify of the underlying
copy number events on a given chromosome, but rather focuses on the identi-
fication of segments of common log2 ratio mean. These segmentation methods
seek to identify locations of log2 ratio mean change (i.e., change points or break-
points) and to estimate the values of those means.
Olshen et al. (2004) proposed a circular binary segmentation (CBS) algorithm
that identifies the change points through successive comparison of segments
of the chromosome and with evaluation of local significance via permutation.
This is followed by a pruning algorithm to control the number of change
points identified. Their method of permutation assumes independence be-
tween clones. Picard et al. (2004) proposed a likelihood-based method to
identify the change points for the sequence of log2 ratios. This method as-
sumes the ratios on a given segment to be independent and normally dis-
tributed with common, unspecified, mean. They employed a dynamic pro-
gramming approach to determine the location of change points. They also in-
corporated penalization to limit the number of estimated change points. Hupe
et al. (2004) likewise presented a Gaussian-based likelihood approach (GLAD).
Change points are identified through use of a piecewise constant regression
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model that employs Adaptive Weights Smoothing (AWS) in which the errors
are assumed to be independent and normally distributed. To explicitly account
for the physical dependence between clones, Fridlyand et al. (2004) proposed
a discrete-state Hidden Markov Model (HMM) approach. This model assumes
that given the genetic states at all “previous” clones, the genetic state at a given
clone depends only on the true state at the immediately previous clone. Of
note, the “states” in the Fridlyand et al. approach are not underlying copy
number events such as gain and loss (as described in Section 3.1), but are seg-
ments of common mean. A change in “state” corresponds to a breakpoint.
Their approach differs from the CBS, Picard et al., and GLAD approaches in
that instead of allowing copy number segments to assume any mean value, the
maximum number of distinct mean values on each chromosome is required
to be pre-selected. They estimate the number of mean levels on each chromo-
some through a penalized likelihood approach (AIC or BIC) followed by an
algorithm that potentially merges adjacent segments. Following segmentation,
they identify genetic features such as focal aberrations and amplifications (low-
and high-level alteration within a segment involving a small number of clones,
respectively) and outliers. Wang et al. (2005) proposed use of an agglomer-
ative clustering technique (CLAC) to identify change points. Their technique
iteratively clusters clones, and subsequently groups of clones, according to a
measure of relative difference between adjacent clones/clusters. They clas-
sify clusters of two or more clones as “interesting” according to the number
of clones in the cluster, the mean log2 ratio value of the cluster, and the value of
the relative difference between adjacent clones within the cluster.
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All of these segmentation methods provide breakpoint locations but do not
identify the associated genomic alterations as gains or losses. Because a pri-
mary objective of aCGH analysis is to identify regions of copy number gain
and loss, follow-up methods have been proposed for this from segmentation
results. First, some authors have used a nonparametric estimate of the standard
deviation to identify a global threshold for categorizing segments (Paris et al.,
2004; Rossi et al., 2005). The threshold is obtained by calculating the median
absolute deviation (MAD) for each identified segment and using the median
of the MADs (MMAD) as an estimate of the standard deviation. Clones on
segments whose magnitude exceeds a multiple of the MMAD are classified as
gains and clones on segments whose magnitude is less than a multiple of the
MMAD are classified as losses.
A second approach to gain and loss identification based on segmentation re-
sults entails the combination of identified segments across chromsomes and
a subsequent establishment of a no-change baseline. Hupe et al. (2004) out-
line a method, GLADmerge, for combining segments obtained from GLAD,
first within, and then across chromsomes through hierarchical clustering in
which clusters of segments are identified from the resultant dendrograms. The
super-cluster with magnitude closest to 0 is labeled as the no-change baseline.
The remaining clusters are labeled as gain or loss. Willenbrock and Fridlyand
(2005) proposed an alternative approach, MergeLevels, which can be applied
to a number of different segmentation methods (e.g., CBS, HMM, etc.). Seg-
ments on a given hybridization are combined (assigned the same magnitude
or level) if 1) the distributions of the log2 ratios on each of the two segments are
10
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not significantly different from one another or 2) if the difference in segment
mean magnitudes falls below a dynamically determined threshold. Following
segment combination, the segment level with magnitude closest to 0 is identi-
fied as the baseline. All other levels are identified as regions of copy number
gains or losses.
3.3 Current Methods: Limitations
A major limitation of all currently proposed methods is their separate analysis
of each chromosome and of each hybridization. These methods do not utilize
all of the available information to estimate the features that are shared in com-
mon among chromosomes and hybridizations. For this reason, they are likely
to be highly inefficient.
An additional limitation of some methods is their failure to account for depen-
dence between clones. Problems that arise from assumptions of independence
are particularly apparent in methods that prespecify the number and type of
underlying copy number events (i.e., Section 3.1). In such approaches, individ-
ual clones whose absolute magnitude exceeds a given magnitude are classfied
as gains or losses regardless of the behavior of adjacent clones. Hence, such
methods can result in a high misclassfication rate.
The methods of Section 3.1 may also suffer from numerical difficulties in the
estimation procedure if the prespecified copy number events such as gain or
loss occur infrequently in a particular chromosome. To avoid these difficulties,
subjective input on a chromosome by chromosome basis would be required,
11
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which is also an undesirable feature. Another limitation of these methods is
that they do not account for intratumoral clonal variation. The use of thresh-
olds entails the assumption that levels of gain and loss are constant across the
chromosome. If, therefore, there is a range of levels of gain and loss due to
clonal variation within the chromosome, the estimated levels of gain and loss
might be biased toward zero (i.e., no-change).
Segmentation methods (Section 3.2) also have a number of limitations. First,
many of the proposed segmentation methods require the use of ad hoc algo-
rithms to prune or combine segments. The sensitivity of segmentation meth-
ods is often dependent upon user-defined values in such algorithms. Second,
interpretation of segmentation results is problematic. That is, once the change
points are identified and associated mean log2 ratio levels are estimated, it is
not at all clear which segments of common mean represent real genetic alter-
ations (i.e., copy number gain or loss) and which are simply due to experimen-
tal variability. The thresholding (MMAD) or pruning and combination (GLAD-
merge and MergeLevels) second-stage methods have been developed to over-
come this drawback. However, these methods must be employed subsequent
to the initial segmentation and are not natural extensions of the original mod-
eling. In fact, classification of gain and loss that is accomplished through these
secondary methods seems to ignore the variability both within and between
chromosomes that motivated the initial use of segmentation (see Fridlyand et
al., 2004). Such methods do appear to have difficulty when there is variation in
copy number levels between chromosomes (see Section 6).
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4 Pseudolikelihood Approach
In this section we outline the theoretical framework for our estimation proce-
dure. We additionally present methods for classification of gains and losses
and for identification of copy number breakpoint locations.
4.1 Notation and Pseudolikelihood Function
Let xim = (xim1, . . . , ximJ) denote the log2 ratios for hybridization i on chro-
mosome m for clones 1, . . . , J , where J may vary across chromosomes and
hybridizations. Assuming independence across chromsomes and across hy-
bridizations, the likelihood of the data is
∏
i
∏
m
P (xim|λ) =
∏
i
∏
m
P (xim1, . . . , ximJ |λ), (4.1)
where λ denotes the array of parameters governing the distribution of xim.
It is plausible that the dependence between clones is local and that clones that
are separated by sufficient distances can be reasonably regarded as indepen-
dent. Of course, specific patterns of dependence across the genome are com-
plex. For example, in examining patterns of recombination, Gabriel et al. (2002)
found that haplotypes (particular combinations of alleles) on different blocks
can be considered independent, whereas those on the same block cannot. How-
ever, due to the complexity of such blocks (e.g., varying length of blocks, dif-
ferences in patterns across populations), incorporation of these patterns into a
model is difficult.
13
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As a close approximation to the truth and for computational simplicity, we
propose a local dependence model. In the setting of spatial data that also ex-
hibited local dependence, Besag (1975) suggested use of a pseudolikelihood
that exploited this dependence structure and treated data points separated by
a given distance as independent. Besag proved consistency of the maximum
pseudolikelihood estimates, and thus provided a theoretical foundation for the
approach. Efficiency of the method was examined by Lindsay (1988). Several
authors employed a similar approach in situations of bivariate association (e.g.,
Clayton, 1978, Oakes, 1986). Recently, Cox and Reid (2004) derived the con-
ditions under which consistent estimators are obtained when using marginal
and bivariate probabilities to form estimating functions from a “pairwise like-
lihood.”
We likewise propose use of a pseudolikelihood as an approximation to
the full likelihood (4.1). In contrast to many previous applications of
pseudolikelihood that used a pairwise (bivariate) likelihood, we construct
a pseudolikelihood as the product of overlapping triples of log2 ratios:∏
i
∏
m
∏J−1
j=2 P (xim(j−1), ximj, xim(j+1)|λ). Note that each log2 ratio contributes
to the pseudolikelihood three times: once as xj−1, once as xj , and once as xj+1.
As suggested by previous authors, a Gaussian finite mixture model provides a
natural formulation of the distribution of the log2 ratios:
∏
i
∏
m
J−1∏
j=2
∑
C
P (xim(j−1), ximj, xim(j+1)|λ,C)P (C|λ), (4.2)
where the vector C contains the set of unobserved states (Cj−1, Cj, Cj+1) cor-
14
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responding to the log2 ratios, xim(j−1), ximj , and xim(j+1). For aCGH data, pos-
sible states include events such as copy number gain, copy number loss, and
no-change (no gain and no loss). The summation over C, then, represents the
summation over all possible state combinations for these three log2 ratios. Al-
though the underlying state of a given log2 ratio is obviously fixed, regardless
of whether the data point is at position j − 1, j, or j + 1, this is not enforced
in (4.2). This is due to our introduction of the mixture model at the level of
the trivariate probability distributions, rather than at the level of the full joint
distribution. We have done this to avoid high dimensional numerical integra-
tion and examine its impact on parameter estimation in our simulation studies
(Section 6).
The array λ in (4.2) is expanded from the array in (4.1) to include the param-
eters governing the mixture distribution, including initial state probabilities
and transition probabilities (e.g., Rabiner, 1989). We assume that it is constant
across all hybridizations, chromosomes, and clones. We also assume that the
log2 ratios corresponding to a particular state are normally distributed with a
state-specific mean and a common variance. Hence, for a Gaussian three-state
model consisting of copy number loss (L), no-change (0), and copy number
gain (G), λ includes the mean and variance parameters governing the distribu-
tions of log2 ratios (µL, µ0, µG, σ), the vector of initial state probabilities (pi), and
the array of transition probabilities (A).
Due to intratumoral clonal variation, it is not reasonable to assume that the
mean levels of gain or loss are constant within or between chromosomal seg-
ments. To account for the variation in mean levels of log2 ratios corresponding
15
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to a particular copy number event, C, we assume that each small neighborhood
of three clones has a random mean level, γC , and that the log2 ratios generated
from that particular state, C, in that neighborhood, have mean, γC , and variance
σ2. We assume that the γC are drawn from a normal distribution with mean µC
and variance σ2C . For identifiability, we assume that the random effects, γL, γ0,
and γG, follow truncated normal distributions such that γL < −ε < γ0 < ε < γG.
In our analyses of real and simulated data, our estimation algorithm converged
for  ∈ (0.1, 0.4) and the results were not sensitive to the actual choice of 
within that range. Under this random effects model, the pseudolikelihood for
the finite mixture model (4.2) is modified to be:
∏
i
∏
m
J−1∏
j=2
∑
C
∫
γ
P (xim(j−1), ximj, xim(j+1)|λ,C, γ)P (γ|λ,C)P (C|λ)
P (γL < −ε)P (|γ0| < ε)P (γG > ε)
dγ, (4.3)
where the random vector γ contains the random means for loss, no-change,
and gain (γL, γ0, γG). The parameter array λ is now expanded to include the
parameters governing the distributions of the random effects: µL, σL, µ0, σ0, µG,
σG.
We assume that conditional on the underlying states, C, and random mean
levels γ, the ximj are independent. Hence,
P (xim(j−1), xim(j), xim(j+1)|λ, γ,C) =
1∏
r=−1
P (xim(j+r)|λ, Cr, γ) =
1∏
r=−1
1
σ
φ
(
xim(j+r) − γcr
σ
)
.
We assume also that the random state means, γ, are mutually independent and
16
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independent of C, so that:
P (γ|λ,C) = P (γL, γ0, γG|λ,C) = P (γL|λ)P (γ0|λ)P (γG|λ)
=
1
σL
φ
(
γL − µL
σL
)
1
σ0
φ
(
γ0 − µ0
σ0
)
1
σG
φ
(
γG − µG
σG
)
.
Finally, we assume that the unobserved states follow a one-step Markov pro-
cess, so that
P (Cj−1, Cj, Cj+1|λ) = P (Cj−1|pi,A)P (Cj|Cj−1, pi,A)P (Cj+1|Cj, pi,A)
= picj−1acj ,cj−1acj+1,cj ,
where ac,c′ denotes the probability of transitioning from state C ′ to state C and
pic denotes the marginal probability of state C.
Following some algebra and a change of variables, closed form evaluation of
the integral in (4.3) is possible, and the pseudolikelihood is re-expressed as
∏
i
∏
m
J−1∏
j=2
∑
C
acj+1,cjacj ,cj−1picj−1dc(xim(j−1), ximj, xim(j+1), λ, ε)
Φ
(
−ε−µL
σL
)
2
(
1− Φ
(
ε−µ0
σ0
)) (
1− Φ
(
ε−µG
σG
)) , (4.4)
where dc(.) is a function specific to each possible triple of hidden state combi-
nations, C, associated with xj−1, xj, xj+1. It is a function of the data, the value
of ε, and the parameters, µL, µ0, µG, σ, σL, σ0, σG, and σ. The model parame-
ters can be estimated by maximizing (4.4) using a simple iterative optimization
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technique, such as Newton-Raphson.
4.2 Posterior Probabilities and Classification of Clones
Following the estimation of parameters, it is of interest to estimate the posterior
probabilities of the underlying states given the observed data. One possible
approach is to calculate P (Cimj = c|ximj). However, this may be inaccurate for
outlying log2 ratios. An alternative approach that may diminish the influence
of outliers is to smooth the data by calculating the probability of a given state
conditional on the corresponding and adjacent log2 ratios:
P (Cimj = c|xim(j−1), ximj, xim(j+1)). (4.5)
Since P (xj−1, xj, xj+1|Cj = c) is equal to
∑
Cj−1
∑
Cj+1
P (xj−1, xj, xj+1|Cj−1, Cj = c, Cj+1)P (Cj−1, Cj+1|, Cj = c),
the probability in (4.5) can be rewritten, by Bayes’ Formula, as
∑
Cj−1
∑
Cj+1
P (xj−1, xj, xj+1|Cj−1, Cj = c, Cj+1)P (Cj−1, Cj+1|Cj = c)P (Cj = c)∑
Cj−1
∑
Cj
∑
Cj+1
P (xj−1, xj, xj+1|Cj−1, Cj, Cj+1)P (Cj−1, Cj, Cj+1)
.
This quantity is calculated based on the assumptions of the model in conjunc-
tion with the parameter estimates. Individual clones could then be assigned to
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the state corresponding to the highest of the three “classification probabilities”:
P (Cj = L|xj−1, xj, xj+1), P (Cj = 0|xj−1, xj, xj+1), P (Cj = G|xj−1, xj, xj+1).
In addition to the posterior probability given in (4.5), two alternative poste-
rior probabilities could be calculated for each clone j: P (Cj = c|xj−2, xj−1, xj)
and P (Cj = c|xj, xj+1, xj+2). These suggest an additional “smoothing” of the
data by averaging the three posterior probabilities and likewise, an additional
option for classification via the averaged probabilities. In our analysis of the
glioma study and in our simulation studies, we classified individual clones us-
ing the averaged posterior probabilities.
4.3 Identification of Breakpoints
Ultimately it is also of interest to identify the locations at which copy num-
ber transitions are likely to have occurred. Locations of such breakpoints are,
in part, visually identifiable through examination of plots of probabilities de-
scribed in Section 4.2. Through inspection of such plots, researchers are pro-
vided with a measure of the strength of evidence there is for each copy number
transition.
Results from the pseudolikelihood method could also be used to more formally
identify these breakpoints. One approach entails the calculation of the proba-
bilities that, conditional on the data triplet xj−1, xj , and xj+1, the state of the
clone Cj differs from either of the states of the adjacent clones Cj−1 and Cj+1.
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These are given by:
P (Cj−1 6= Cj 6= Cj+1|xj−1, xj, xj+1)
P (Cj−1 = Cj 6= Cj+1|xj−1, xj, xj+1)
P (Cj−1 6= Cj = Cj+1|xj−1, xj, xj+1).
The maximum of the three probabilities could be plotted on the graphical dis-
play or it could be used in conjunction with a threshold to identify high proba-
bility breakpoint locations.
5 Glioma Study
Classification of human gliomas based on molecular genetic alterations has al-
ready achieved clinical relevance (Cairncross et al., 1998; Smith et al., 2000;
Smith et al., 2001; Sasaki et al., 2002; Nutt et al., 2003; van den Bent et al.,
2003). Among the major subtypes of gliomas, oligodendrogliomas are distin-
guished by their sometimes remarkable sensitivity to chemotherapy. While no
clinical or histopathologic feature of these tumors allows accurate prediction
of their response to chemotherapy, allelic loss of chromosome 1p is a strong
predictor of chemosensitivity, and combined loss of chromosome 1p and 19q
is statistically significantly associated with both chemosensitivity and longer
recurrence-free survival after chemotherapy (Cairncross et al., 1998). Loss of 1p
also appears to have prognostic importance in low-grade oligodendrogliomas
(Sasaki et al., 2002; van den Bent et al., 2003). Tumors without 1p loss are asso-
20
http://biostats.bepress.com/harvardbiostat/paper30
ciated with more aggressive behavior. A recent study (Mohapatra et al., 2006)
was undertaken to evaluate the genetic features of oligodendroglial tumors at a
much finer resolution than had been used in previous studies, which used the
older, low-throughput techniques of loss of heterozygosity (LOH) and FISH.
The 28 gliomas included 10 grade II oligodendrogliomas, 9 anaplastic oligoden-
drogliomas, 1 grade II oligoastrocytoma and 8 anaplastic oligoastrocytomas.
While the ultimate goal of the glioma study is to identify novel regions of loss
or gain that are shared by patients with oligodendroglial tumors, the first step is
to determine regions of loss or gain within individual patients. For each of the
28 subjects in the study, we obtained aCGH data from BAC arrays containing
clones from chromosomes 1, 7, 19, and X. We compared the results of our pro-
posed method to results obtained using the MergeLevels approach proposed
by Willenbrock and Fridlyand based on segments identified by the CBS change
point detection method of Olshen et al.
Prior to analysis, we normalized the data. Due to the high percentage of loss
and low percentage of gain in the data, median-centered normalization was
not effective and it did not center the no-change regions at 0. The experiment
included three normal-normal hybridizations, which could be used for nor-
malization. However, due to the variability across individuals, this also was
inadequate. As patients with oligodendroglial brain tumors typically do not
exhibit genetic alterations on chromosome 1q, we centered each hybridization
about the median of its 1q log2 ratios.
Using the normalized data, we estimated the parameters of the model using
our proposed pseudolikelihood function (4.4) and we calculated the averaged
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posterior probabilities. We then assigned each clone to the state corresponding
to the highest of its three posterior probabilities. We used the truncating value,
ε = 0.20; the results were not sensitive to the precise value of ε within (0.1,0.4).
Figures 2 and 3 contain the data from four tumors and analysis results from
the proposed method along with those obtained from the MergeLevel-CBS
method. The probabilities of loss provided by the pseudolikelihood method
are represented by the vertical red lines, extending from the bottom of the fig-
ure upward, and their values are the associated values on the left axis. The
probabilites of gain are represented by the vertical blue lines, extending from
the top of the figure downward, and their values are calculated as one minus
the associated value on the left axis (or simply their lengths, measured using
the scale on the left axis). The probabilities of no-change are represented by
the white lines, in the middle of the figure, between the red and the blue lines.
Their values are calculated as one minus the probabilities of loss and gain (or
simply their lengths, measured using the scale on the left axis). For example, in
Figure 2(a), the pseudolikelihood method yields posterior probabilities of loss
that are close to 1 for all clones on chromosome 1p. The posterior probabilities
of gain for one of the segments on chromosome 1q is close to 0.2 (i.e., the blue
lines extend downward to about 0.8). The right axis in the figures refers to the
log2 scale. The vertical dashed lines demarcate the chromosomes. The horizon-
tal solid green lines drawn through the data points on each chromosome rep-
resent the mean log2 levels for the segments estimated by the MergeLevel-CBS
method. The original CBS segmentation results are denoted by the horizontal
solid black lines. For the tumors in Figures 2 and 3, we also formally identified
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breakpoints using the method outlined in Section 4.3: locations at which the
maximum of the three probabilities exceeded a threshold of 0.6 were identified
as breakpoints. Breakpoints in both figures are denoted by black tick marks
extending below the zero probability level of the plots.
For the hybridizations depicted in Figure 2, there is general agreement among
all three methods. For the hybridization shown in Figure 2(a), loss is detected
by all three methods at 1p and 19q. All three methods find no-change on 1p and
19q for the hybridization shown in Figure 2(b). One difference between the two
plots is instructive. The tumor displayed in Figure 2(a) contains an apparent
small region of low-level gain on 1q, as does the tumor in Figure 2(b) on 19p.
These regions are flagged by the pseudolikelihood method (blue downward
spikes) and the corresponding quantitative assessments of the probability of
gain are low: 0.30 – 0.40. The CBS method identifies a change point demarcat-
ing the relatively large segment of transition on 1q in Figure 2(a), but does not
identify the smaller segment on 19p in Figure 2(b). Since 1q has been used as
a basis for normalization, it should be noted that either any gains on this arm
should be viewed as suspect or the justification for the normalization should
be revisited. Nevertheless, it is difficult to assess from the CBS method the ex-
tent to which those identified segments should be viewed as true alterations or
as segments due to chance variation. The MergeLevels-CBS method does not
identify a gain at either location.
The results shown in Figure 3 illustrate an increased sensitivity of the pseu-
dolikelihood method relative to the CBS and MergeLevels-CBS methods with
regard to small regions of apparent within-chromosome change. Figure 3(a)
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illustrates a case for which there appears to be copy number alteration on a
small region of chromosome 7 (i.e., at the EGFR gene). EGFR amplification for
that case was, in fact, confirmed by FISH. The pseudolikelihood method iden-
tifies this region exactly. In contrast, the CBS method in effect averages this
small region of amplification with the normal copy numbers from the remain-
ing part of the chromosome and identifies a lower level of transition across the
entire chromosome. The MergeLevels-CBS method does not categorize any of
the clones on chromosome 7 as copy number gains. Figure 3(b) similarly illus-
trates identification of multiple regions of loss at 19q by the pseudolikelihood
method, versus identification of loss of the entire chromosome arm by CBS and
MergeLevels-CBS.
6 Simulation Study
We conducted simulation studies to investigate the performance of the pseudo-
likelihood method under a variety of conditions. We completely specified the
parameters of the model, from which we generated both the state vector, C, and
the log2 ratios. Each of the 5000 simulated data sets contained 15 hybridizations,
each hybridization consisted of five chromosomes, and each chromosome con-
sisted of 50 clones. For each simulated data set, we calculated misclassifica-
tion rates (see Section 4.2) for the pseudolikelihood method by comparing the
classification results to the truth, i.e., C. We also analyzed the data using the
MergeLevels-CBS approach. We compared the MergeLevels-CBS classification
results to the truth (C) to obtain its misclassification rate. We then averaged
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the misclassfication rates over all 5000 simulated data sets. We did not study
the MergeLevels results using segments identified by other approaches such
as the HMM method of Fridlyand et al. Likewise, we did not compare results
to other methods such as GLADmerge. We made the choice because results
of these methods have been shown to be similar to those obtained using the
MergeLevels-CBS approach (Willenbrock and Fridlyand, 2005). In fact, these
authors found that among these methods the MergeLevels-CBS approach “has
the best operational characteristics in terms of its sensitivity and FDR for break-
point detection.”
We initially selected parameter values for the data generation process that were
similar to those that we estimated for the glioma data. However, while these
data exhibited variation in the mean levels of gain and loss, there were very
few copy number transitions; instead, there were whole chromosome losses.
Hence, we increased the transition probabilities to yield data with more genetic
alteration and with small regions of loss and gain. The resultant simulated
data sets exhibited extensive noise due both to mean level variation and to
a large number of state transitions. Figure 4 depicts a single realization of a
simulated high-transition hybridization. True copy number losses are denoted
with circles and gains are denoted with triangles. We used ε = 0.2 in all of the
analyses.
Simulation results for the high-transition data are listed in Tables 1 and 2. Table
1 contains the parameter estimates. The model parameters that are not listed in
Table 1 are functions of those that are specified. Table 2 lists the average mis-
classifcation rates of both the pseudolikelihood and MergeLevels-CBS analy-
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ses. False positivies are gains or losses identified by the respective method that
were not actually present. False negatives are true gains or losses that were
missed by the method. Results in Tables 1 and 2 under the heading “HM”
(for hybridization-specific means) were obtained for data that were generated
under a model in which a single mean for each of the states of loss, gain and
no-change (i.e., a single γL, γG, γ0) was generated for each hybridization. Given
the true state vector C, and the generated state means, the log2 ratios were
then generated. The results under the heading “CM” (for chromosome-specific
means) were obtained for data that were generated under a model in which
different realizations of the state means, γL, γG, γ0, were generated for each
chromosome. Lastly, the results under the heading “HV” (for hybridization-
specific variances) were obtained from data that were generated under a model
in which the variability of the log2 ratios varied across hybridizations. Specif-
ically, we allowed σ to vary normally across hybridizations with mean 0 and
standard deviation 0.045. These data violate the assumption of the pseudo-
likelihood approach that the variability of the log2 ratios is constant across hy-
bridizations. We examined this violation to assess the robustness of our ap-
proach, because in reality, some hybridizations are “noisier” than others.
We also examined the performance of both methods on data sets with fewer
copy number transitions, i.e., low-transition data. Figure 5 displays a single
realization of a simulated low-transition hybridization. Tables 3 and 4 contain
the results of these simulation studies.
Overall, the pseudolikelihood method resulted in accurate parameter estima-
tion for both high- and low-transition data (see Tables 1 and 3). Not surpris-
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Table 1: Parameter estimates (MSE’s) for high-transition data from simulation study1
Parameter True value HM2 CM3 HV4
µL −0.755 −0.754 (4.5E−3) −0.752 (1.9E−3) −0.734 (5.3E−3)
µ0 0.000 0.000 (3.0E−4) 0.000 (7.6E−5) 0.000 (3.1E−4)
µG 0.613 0.637 (4.4E−3) 0.631 (1.7E−3) 0.622 (4.1E−3)
σ2 0.032 0.033 (3.7E−6) 0.033 (3.2E−6) 0.032 (1.3E−5)
σ2L 0.050 0.045 (4.5E−4) 0.048 (2.0E−4) 0.049 (4.4E−4)
σ20 0.005 0.003 (4.5E−6) 0.003 (3.6E−6) 0.003 (5.2E−6)
σ2G 0.051 0.038 (4.4E−4) 0.041 (1.9E−4) 0.040 (3.7E−4)
piL 0.080 0.076 (1.0E−4) 0.076 (7.7E−5) 0.082 (1.5E−4)
piG 0.080 0.080 (1.5E−4) 0.081 (1.0E−4) 0.085 (1.7E−4)
aG0 0.038 0.036 (3.7E−5) 0.037 (2.5E−5) 0.041 (5.8E−5)
aLG 0.100 0.097 (3.4E−4) 0.099 (3.1E−4) 0.101 (3.8E−4)
a0L 0.400 0.413 (1.3E−3) 0.412 (1.2E−3) 0.418 (1.4E−4)
1 Study consisted of 5000 repetitions of 15 simulated hybridizations.
Each hybridization consisted of 5 chromosomes with 50 clones apiece.
2 HM: data sets in which state means (γ’s) varied across hybridizations
3 CM: data sets in which state means varied across chromosomes
4 HV: data sets in which the variance of the log2 ratios (σ) varied across
hybridizations
Table 2: Pseudolikelihood and Merge-Levels-CBS misclassification rates for high-
transition data from simulation study
Data set Error type Pseudolikelihood MergeLevels-CBS
HM1 False positive 0.0098 0.0113
HM False negative 0.0324 0.1340
HM Total 0.0422 0.1454
CM2 False positive 0.0100 0.1341
CM False negative 0.0322 0.1145
CM Total 0.0422 0.2486
HV3 False positive 0.0173 0.0150
HV False negative 0.0304 0.1335
HV Total 0.0477 0.1485
1 HM: data sets in which state means (γ’s) varied
across hybridizations
2 CM: data sets in which state means varied across
chromosomes
3 HV: data sets in which the variance of the log2
ratios (σ) varied across hybridizations
27
Hosted by The Berkeley Electronic Press
Table 3: Parameter estimates (MSE’s) for low-transition data from simulation study1
Parameter True value HM2 CM3 HV4
µL −0.755 −0.750 (6.4E−3) −0.751 (4.7E−3) −0.739 (7.6E−3)
µ0 0.000 0.000 (3.0E−4) 0.000 (7.6E−5) 0.000 (3.2E−4)
µG 0.613 0.630 (6.9E−3) 0.629 (4.3E−3) 0.620 (6.1E−3)
σ2 0.032 0.033 (2.1E−6) 0.033 (1.7E−6) 0.033 (1.4E−5)
σ2L 0.050 0.043 (6.1E−4) 0.046 (4.3E−4) 0.044 (5.8E−4)
σ20 0.005 0.003 (4.3E−6) 0.003 (3.2E−6) 0.003 (5.0E−6)
σ2G 0.051 0.036 (5.8E−4) 0.039 (3.8E−4) 0.036 (5.2E−4)
piL 0.080 0.078 (4.9E−4) 0.079 (4.7E−4) 0.081 (4.8E−4)
piG 0.080 0.080 (4.6E−4) 0.081 (4.6E−4) 0.083 (5.1E−4)
aG0 0.004 0.005 (4.8E−6) 0.005 (4.7E−6) 0.007 (1.7E−5)
aLG 0.020 0.021 (1.6E−4) 0.021 (7.0E−5) 0.023 (1.0E−4)
a0L 0.039 0.059 (5.8E−4) 0.058 (5.8E−4) 0.069 (1.3E−3)
1 Study consisted of 5000 repetitions of 15 simulated hybridizations.
Each hybridization consisted of 5 chromosomes with 50 clones apiece.
2 HM: data sets in which state means (γ’s) varied across hybridizations
3 CM: data sets in which state means varied across chromosomes
4 HV: data sets in which the variance of the log2 ratios (σ) varied across
hybridizations
Table 4: Pseudolikelihood and MergeLevels-CBS misclassification rates for low-
transition data from simulation study
Data set Error type Pseudolikelihood MergeLevels-CBS
HM False positive 0.0046 0.0124
HM False negative 0.0173 0.0155
HM Total 0.0219 0.0279
CM False positive 0.0046 0.1148
CM False negative 0.0177 0.0142
CM Total 0.0223 0.1291
HV False positive 0.0085 0.0123
HV False negative 0.0176 0.0160
HV Total 0.0261 0.0283
1 HM: data sets in which state means (γ’s) varied
across hybridizations
2 CM: data sets in which state means varied across
chromosomes
3 HV: data sets in which the variance of the log2
ratios (σ) varied across hybridizations
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ingly, the MSE’s are slightly larger for the HV data sets than for the HM and
CM data sets. Also, our procedure appears to perform slightly better on the
CM data than on the HM data with regard to parameter estimation.
The pseudolikelihood method also performs well with regard to classification
of clones. For the high-transition data (e.g., Figure 4) in which there is substan-
tial chromosomal instability, the false negative rate of the pseudolikelihood ap-
proach is roughly a third of that of the MergeLevels-CBS approach in the all
three settings settings. With regard to the false positive rate, the performance
of the two methods is similar in the HM and HV settings. In the CM settings,
however, when copy number mean levels vary across chromosomes within a
hybridization, the pseudolikelihood method has a much lower false positive
rate than the MergeLevels-CBS approach. For low-transition data (e.g., Figure
5) in which there is greater chromosomal stability and fewer small copy num-
ber transitions, the false negative error rates for both methods are similar in all
three settings. False postive rates are also similar in the HM and HV settings.
Again, however, in the CM setting the pseudolikelihood method has a much
lower false positive rate than the MergeLevels-CBS approach. Also of note, the
misclassification rates of pseudolikelihood method for the HV data are similar
to those of the HM and CM data, for both the high- and low-transition models.
This again suggests that the pseudolikelihood model is robust to departures
from the assumption of constant variance.
Two separate shortcomings of the MergeLevels-CBS approach seem to be ap-
parent in these results. First, the high false negative error rates for the high-
transition data suggest that the MergeLevels-CBS approach is less sensitive to
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small regions of copy number alteration than the pseudolikelihood approach.
It appears that through combination of segments across chromosomes, small
regions of change (which are numerous in high-transition data) are combined
with larger regions of no-change. Hence, true changes are missed, resulting in
a high false negative rate. Second, the high false positive error rates in the CM
setting suggest that the MergeLevels-CBS approach has difficulty in account-
ing for variability in mean log2 ratio values for gain and loss for both high-
and low-transistion data and often does not combine segments from the same
genetic alteration type. Thus, when the no-change level is then identified, a
number of true no-change segments are misclassified as gains or losses, result-
ing in a high false positive rate.
We lastly conducted a small simulation study to assess whether the simultane-
ous analysis of chromosomes and hybridizations conducted by the pseudolike-
lihood approach is indeed advantageous relative to single chromosome anal-
yses and to assess the performance of the model in small sample sizes (i.e.,
single chromosome consisting of 50 clones). Using the same methods as above,
we generated data for five chromosomes. First, we analyzed each of the five
chromosomes separately and calculated the misclassification rates using total
numbers of misclassifications across the five analyses. Then we analyzed the
five chromosomes jointly and calculated the misclassification rate. We repeated
this using 500 simulations.
The results for high- and low-transition data, all generated under the CM
model with the same parameter values as in Tables 1 and 3, are contained in
Tables 5 and 6, respectively. We then varied some of these parameters to ob-
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Table 5: Comparison of single chromsome analysis versus simultaneous analysis of
multiple chromosomes for high-transition data from simulation study1
Data Set Parameters Error type Single† Multiple‡
I2 σ2 = 0.032 False positive 0.0319 0.0145
(σ2L, σ
2
0, σ
2
G) = (0.05, 0.005, 0.05) False negative 0.0283 0.0304
(µL, µG) = (−0.755, 0.613) Total 0.0602 0.0449
II3 σ2 = 0.064 False positive 0.0432 0.0327
(σ2L, σ
2
0, σ
2
G) = (0.05, 0.005, 0.05) False negative 0.0488 0.0493
(µL, µG) = (−0.755, 0.613) Total 0.0920 0.0820
III4 σ2 = 0.032 False positive 0.0442 0.0232
(σ2L, σ
2
0, σ
2
G) = (0.10, 0.010, 0.10) False negative 0.0353 0.0395
(µL, µG) = (−0.755, 0.613) Total 0.0795 0.0627
IV5 σ2 = 0.032 False positive 0.0290 0.0192
(σ2L, σ
2
0, σ
2
G) = (0.05, 0.005, 0.05) False negative 0.0616 0.0617
(µL, µG) = (−0.500, 0.500) Total 0.0906 0.0809
1 Study consisted of 500 simulated hybridizations. Each hybridization
consisted of 5 chromosomes with 50 clones apiece.
2 Data simulated using parameters Table 1
3 Same as I, except variability (σ2) of the log2 ratios was doubled
4 Same as I, except variability of the random effects (γl, γ0, γG)
was doubled
5 Same as I, except magnitudes of gain and loss means (µG and µL)
were decreased
† Five chromosomes analyzed separately
‡ Five chromsomes analyzed simultaneously
tain three additional scenarios: (1) larger σ2 (variability of the log2 ratios), (2)
larger σ2l , σ20, σ2G (variability of the random effects, γL, γ0, γG), (3) decreased mag-
nitudes of µL and µG (mean levels for gain and loss).
In this small study we found that for both high- and low-transition data, the
performance of the pseudolikelihood method is improved through the simul-
taneous analysis of multiple chromosomes. For high-transition data, the sin-
gle chromosome analysis total misclassification rate is roughly 50% larger than
that of the simultaneous chromosome analysis and for low-transition data it
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Table 6: Comparison of single chromsome analysis versus simultaneous analysis of
multiple chromosomes for low-transition data from simulation study1
Data Set Parameters Error type Single† Multiple‡
I2 σ2 = 0.032 False positive 0.0364 0.0143
(σ2L, σ
2
0, σ
2
G) = (0.05, 0.005, 0.05) False negative 0.0144 0.0139
(µL, µG) = (−0.755, 0.613) Total 0.0508 0.0282
II3 σ2 = 0.064 False positive 0.0362 0.0282
(σ2L, σ
2
0, σ
2
G) = (0.05, 0.005, 0.05) False negative 0.0239 0.0269
(µL, µG) = (−0.755, 0.613) Total 0.0601 0.0551
III4 σ2 = 0.032 False positive 0.0464 0.0223
(σ2L, σ
2
0, σ
2
G) = (0.10, 0.010, 0.10) False negative 0.0232 0.0240
(µL, µG) = (−0.755, 0.613) Total 0.0696 0.0463
IV5 σ2 = 0.032 False positive 0.0365 0.0141
(σ2L, σ
2
0, σ
2
G) = (0.05, 0.005, 0.05) False negative 0.0375 0.0379
(µL, µG) = (−0.500, 0.500) Total 0.0740 0.0520
1 Study consisted of 500 simulated hybridizations. Each hybridization
consisted of 5 chromosomes with 50 clones apiece.
2 Data simulated using parameters Table 3
3 Same as I, except variability (σ2) of the log2 ratios was doubled
4 Same as I, except variability of the random effects (γL, γ0, γG)
was doubled
5 Same as I, except magnitudes of gain and loss means (µG and µL)
were decreased
† Five chromosomes analyzed separately
‡ Five chromsomes analyzed simultaneously
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is roughly twice as large. This difference is due to the fact that single chro-
mosomes are much more informative for high-transition data than for low-
transition data and thus the advantage of the simultaneous analysis is greater
for low-transition data. The advantage in error rate of the simultaneous anal-
ysis is entirely due to a decrease in false positive rate. This occurs because the
single chromosome analysis gives greater weight to log2 outliers than does the
simultaneous analysis and hence results in a higher false positive rate. The
multiple chromsome analysis corrects for this, but in doing so, misses a few
copy number changes that are real, and thus its false negative rate is not dimin-
ished relative to the single chromosome analysis. Even in the single chromo-
some analysis, however, total misclassfication rates are still an improvement
over those obtained through use of the MergeLevels-CBS approach (see Tables
2 and 4). Hence, the approach is advantageous even in small sample situations.
7 Discussion
We have proposed an analytic approach for aCGH data that exploits features
that are shared in common among chromosome and hybridizations, while al-
lowing for variation among these same units. We have shown that this ap-
proach is an improvement over currently used methods both in identifying
small regions of copy number gain and loss and in classifying regions of change
when intratumoral clonal variation is present. Furthermore, we have shown
that the method does in fact borrow strength across chromosomes and that by
utilizing all available data, results in improved identification of copy number
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alterations. Finally, the pseudolikelihood method yields easily interpretable
graphical output, allowing researchers to identify regions of possible copy
number gain and loss and to understand their associated probabilities.
While we did allow for variability in the mean levels for loss and gain and
no-change, we did not allow for variability in the transition or state probabil-
ities, i.e., the pi’s and a’s. In reality, however, it is suspected that certain areas
on a given chromosome and that certain chromosomes are more susceptible to
change in copy number than others (Gabriel et al., 2002). Additionally, there is
probably an interactive effect between individuals and chromosomal suscepti-
bility to copy number change. In future work we will investigate the feasibility
of treating these probabilities as random effects within the modeling frame-
work that we have proposed in this paper, thereby allowing for this likely vari-
ability. It will be of interest to ascertain whether this added flexibility further
improves the error rates.
Furthermore, we did not allow for the variability of the observed log2 ratios to
vary across individuals. However, for both biological and experimental rea-
sons, it is likely that it does. Nonetheless, in our simulations we found that it
may not be necessary to build this into our estimation procedure, as the perfor-
mance of our procedure is robust to changes in variability.
A major contribution of our estimation procedure is its ability to conduct simul-
taneous analysis of an entire experiment. One question that arises in this regard
is that of consistency of the estimates. In our simulation of single chromosomes
consisting of 50 clones each (a very small sample size given current arrays) in
which gains and losses were often absent, the method performed well, assign-
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ing very low probabilities of gain and loss. The robustness of this procedure
is, in part, due to the use of the truncation parameter, ε, which assists in the
identifiability of the three state means. Nonetheless, despite these promising
results, it may be advantageous to include a penalty term in the pseudolikeli-
hood function to obtain consistency in certain situations. Analogous to Cox and
Reid’s (2004) use of the univariate likelihood in their penalty for the pairwise
likelihood function, we might use the pairwise likelihood in the penalty for our
trivariate pseudolikelihood. This is a topic of interest for future research.
An additional major contribution of our method is its output of quantitative
assessments of the likelihood of the various genetic alterations at each clone.
This is not provided by the competing segmentation methods of Olshen et al.
(2004) and Fridlyand et al. (2004). An obvious and important extension of
our procedure will be the derivation of confidence intervals for the posterior
probabilities of the different genetic states. This will be possible through the
framework of Generalized Estimation Equations (GEE). Also, we will need to
develop a clear graphical display for our results that incorporates the estimates
of variability afforded by the confidence intervals. Finally, we have proposed
a model-based assessment of breakpoint locations, either as probabilities or as
thresholded outcomes. Further research remains to be done on the optimal
method for identification of these breakpoints.
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(a) Loss is identified at both 1p and 19q by all meth-
ods.
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(b) No-change is detected at both 1p and 19q by all
methods.
Figure 2: Two examples in which all three methods agree in their identification of seg-
ments of loss and gain. The axis on the right is on the probability scale. The axis on
the left is on the log2 scale. The thin black and thick green horizontal lines represent
CBS and MergeLevels-CBS segments, respectively. The blue and red vertical bars indi-
cate the posterior probabilities of gain and loss, respectively. Breakpoints identified by
the pseudolikelihood method are denoted by the tick marks extending below the zero
probability level in each plot.
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(a) A small region of within-chromosome amplifi-
cation on 7 is identified by the pseudolikelihood
method. In contrast, the CBS method identifies
a lower level of gain on the entire chromosome.
MergeLevels-CBS does not recognize any gain on 7.
0.0
0.2
0.4
0.6
0.8
1.0
−2
−1.5
−1
−0.5
0
0.5
1
1.5
2
1p 1q 7 19p 19q X
(b) Loss is identified on regions of 19q by the pseudo-
likelihood method. The entire arm is categorized as
loss by both CBS and MergeLevels-CBS.
Figure 3: Two examples that demonstrate the pseudolikelihood’s increased sensitiv-
ity to within-chromosome change in comparison to CBS and MergeLevels-CBS. Break-
points identified by the pseudolikelihood method are denoted by the tick marks ex-
tending below the zero probability level in each plot.
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Figure 4: An example of a simulated hybridization generated using high transition
probabilities along with results of pseudolikelihood, original CBS analysis results (thin
black horizontal lines), and MergeLevels-CBS results (thick green horizontal lines).
Clones at which a true copy number loss exists are denoted by a circle around the
data point. Clones at which a true copy number gain exists are similarly denoted by
a triangle. Breakpoints identified by the pseudolikelihood method are also identified
for both tumors by the tick marks extending below the zero probability level of each
figure.
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Figure 5: An example of a simulated hybridization generated using low-transition
probabilities along with results of pseudolikelihood, original CBS analysis results (thin
black horizontal lines), and MergeLevels-CBS results (thick green horizontal lines).
Clones at which a true copy number loss exists are denoted by a circle around the
data point. Clones at which a true copy number gain exists are similarly denoted by
a triangle. Breakpoints identified by the pseudolikelihood method are also identified
for both tumors by the tick marks extending below the zero probability level of each
figure.
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